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background: Fatal ventricular arrhythmias in the early period of life have been associated with cardiac channelopathies for decades, and 
postmortem analyses in SIDS victims have provided evidence of this association. However, the prevalence and functional properties of cardiac ion 
channel mutations in infantile fatal arrhythmia cases are not clear.
methods: Seven infants with potentially lethal arrhythmias at age < 1 year (5 males, age of onset 44.1±72.1days) were genetically analyzed for 
KCNQ1, KCNH2, KCNE1-5, KCNJ2, SCN5A, GJA5, and CALM1 by using denaturing high-performance liquid chromatography and direct sequencing. 
Whole-cell currents of wild-type and mutant channels were recorded and analyzed in Chinese hamster ovary cells transfected with SCN5A and 
KCNH2 cDNA.
results: In 5 of 7 patients, we identified 4 mutations (p.N1774D, p.T290fsX53, p.F1486del and p.N406K ) in SCN5A, and 1 mutation (p.G628D) in 
KCNH2. N1774D, F1486del, and N406K in SCN5A displayed tetrodotoxin-sensitive persistent late Na+ currents. By contrast, SCN5A-T290fsX53 was 
non-functional. KCNH2-G628D exhibited loss of channel function.
conclusions: Genetic screening of 7 patients was used to demonstrate the high prevalence of cardiac channelopathies. Functional assays 
revealed both gain and loss of channel function in SCN5A mutations, as well as loss of function associated with the KCNH2 mutation.
